NCT06620796 2024-10-01A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung CancerShanghai Pulmonary Hospital, Shanghai, ChinaPhase 2 Not yet recruiting70 enrolled